
Tripti™ is a cold-water dispersible powder containing 90% Oleoylethanolamide (OEA) as its active ingredient, combined with up to 10% LipiSperse® — a proprietary dispersion technology. It is specifically designed for integration into powdered drinks, effervescent powders, tablets, and capsules.
Trpti™ is manufactured in Australia by Pharmako Biotechnologies Pty Ltd. The active ingredient OEA is synthesized from oleic acid and ethanolamine. The LipiSperse® delivery system is composed of botanical and semi-synthetic dispersants including fractionated coconut oil, sunflower lecithin, mono and diglycerides of fatty acids, and polyglycerol esters of fatty acids.




